Browse > Article

Effects of Saengmaekcheongpye-eum on LPS-Induced COPD Model  

Kim, Yong (Division of Respiratory System, Dept. of Internal Medicine, College of Oriental Medicine, Dae-jeon University)
Yang, Su-Young (Division of Respiratory System, Dept. of Internal Medicine, College of Oriental Medicine, Dae-jeon University)
Kim, Min-Hee (Dept. of Neurophysiology, College of Oriental Medicine, Dae-jeon University)
NamGung, Uk (Dept. of Neurophysiology, College of Oriental Medicine, Dae-jeon University)
Park, Yang-Chun (Division of Respiratory System, Dept. of Internal Medicine, College of Oriental Medicine, Dae-jeon University)
Publication Information
The Journal of Internal Korean Medicine / v.32, no.2, 2011 , pp. 217-231 More about this Journal
Abstract
Objectives : This study aimed to evaluate the effects of Saengmaekcheongpye-eum (SCE) on a LPS-induced COPD (chronic obstructive pulmonary disease) model. Materials and Methods : The extract of SCE was treated to A549 cells and and LPS-induced COPD mouse model. Then, various parameters such as cell-based cyto-protective activity and histopathological finding were analyzed. Results : SCE showed a protective effect on LPS-induced cytotoxicity in A549 cells. This effect was correlated with analysis for caspase 3 levels, elastin contents, protein levels of cyclin B1, Cdc2, and phospho-Erk1/2, and gene expression of TNF-${\alpha}$ and IL-$1{\beta}$ in A549 cells. SCE treatment also revealed a protective effect on LPS-induced lung injury in COPD mouse model. This effect was evidenced via histopathological findings including immunofluorescence stains against elastin and caspase 3, and protein levels of cyclin B1, Cdc2, and Erk1/2 in lung tissue. Conclusions : These data suggest that SCE has pharmaceutical properties on lung injury. This study thus provides scientific evidence for the efficacy of SCE for clinical application to patients with COPD.
Keywords
Saengmaekcheongpye-eum; chronic obstructive pulmonary disease; emphysema; A549 cell;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F 2nd, Park DR, et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164:1896-903.   DOI   ScienceOn
2 Guo R, Pittler MH, Ernst E. Herbal medicines for the treatment of COPD: a systematic review. Eur Respir J 2006;28(2):330-8.   DOI   ScienceOn
3 Nakajoh M, Fukushima T, Suzuki T, Yamaya M, Nakayama K, Sekizawa K, et al. Retinoic acid inhibits elastase-induced injury in human lung epithelial cell lines. Am J Respir Cell Mol Biol 2003;28:296-304.   DOI   ScienceOn
4 Fiorenza D, Viglio S, Lupi A, Baccheschi J,Tinelli C, Trisolini R, et al. Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report. Respir Med 2002;96(2):110-4.   DOI   ScienceOn
5 Cocci F, Miniati M, Monti S, Cavarra E, Gambelli F, Battolla L, et al. Urinary desmosine excretion is inversely correlated with the extent of emphysema in patients with chronic obstructive pulmonary disease. Int J Biochem Cell Biol 2002;34(6):594-604.   DOI   ScienceOn
6 Yu SA, Kim SC, Jo MS, Suh DS, Kim KH, Yoon MS. Anti-proliferation effect in epithelial ovarian cancer cells by MEK inhibitor AZD6244. Korean J Obstetrics and Gynecology 2010;53:243-53.   DOI   ScienceOn
7 Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995;107:1062-73.   DOI   ScienceOn
8 Martin TR. Recognition of bacterial endotoxin in the lungs. Am J Respir Cell mol Biol 2000;23(2):128-32.   DOI   ScienceOn
9 전국한의과대학 본초학교실. 本草學. 서울: 영림사; 1994, p. 420-623.
10 Gross D, Shenkman Z, Bleiberg B, Dayan M, Gittelson M, Efrat R. Ginseng improves pulmonary functions and exercise capacity in patients with COPD. Monaldi Arch Chest Dis 2002;57(5-6):242-6.
11 Xie YC, Dong XW, Wu XM, Yan XF, Xie QM. Inhibitory effects of flavonoids extracted from licorice on lipopolysaccharide-induced acute pulmonary inflammation in mice. Int Immunopharmacol 2009;9(2):194-200.   DOI   ScienceOn
12 Cosio MG, Cosio Piqueras MG. Pathology of emphysema in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 2000;55(2): 124-9.
13 Piquet J, Maurer C, Barbieux H, Chavaillon JM, Debieuvre D, Lebas FX, et al. Acute exacerbations of COPD admitted to hospital: predictive factors of 3 year mortality. Rev Mal Respir 2007;24:909-16.   DOI   ScienceOn
14 Tetley TD. Macrophages and the pathogenesis of COPD. Chest 2002;121(5 Suppl):S156-9.   DOI
15 Mak JC, Ho SP, Yu WC, Choo KL, Chu CM, Yew WW, et al. Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD. Eur Respir J 2007;30(4):684-90.   DOI   ScienceOn
16 The National Lung Health Education Program (NLHEP). Strategies in preserving lung health and preventing COPD and associated diseases. Chest 1998;113:123S-63S.   DOI   ScienceOn
17 전국한의과대학 폐계내과학교실. 동의폐계내과학. 서울: 한문화사; 2002, p. 335-46.
18 Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355-65.   DOI   ScienceOn
19 Vadas P, Browning J, Edelson J, Pruzanski W. extracellular phospholipase A2 expression and inflammation. J Lipid Mediat 1993;8:1-8.
20 김선영, 김창환, 김태규, 김희제, 서영훈, 성정석, 등. 면역학 제2판. 서울: 라이프사이언스; 2006, p. 223-73.
21 허준. 동의보감. 서울: 남산당; 1986, p. 482.
22 오지석, 박양춘. 加味八味丸의 elastase 유도성 A549 세포사멸에 대한 보호효과. 대한한의학회지 2010;31(2):137-48.
23 Torres A, Dorca J, Zalacaín R, Bello S, El-Ebiary M, Molinos L, et al. Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. Am J Respir Crit Care Med 1996;154:1456-61.   DOI   ScienceOn
24 Soler-Cataluna JJ, Martinex-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60:925-31.   DOI   ScienceOn
25 장준. 만성 폐쇄성 폐질환의 약물치료. 대한결핵 및 호흡기학회지 2005;59(3):231-42.
26 Lee DJ. The effects of Lonicera japonica on the murine model of Chronic obstructive pulmonary disease. 학위논문(박사). 경희대학교대학원; 2009.
27 김기태, 고흥. 柴梗半夏湯이 LPS로 유발된 급성 폐손상에 대한 영향. 동의생리병리학회지 2009;26:1349-57.
28 윤종만, 박양춘. Elastase 매개성 폐조직 손상에 대한 선폐정천탕의 보호효과. 대한한방내과학회지 2010;31(1):84-101.
29 Celli BR. ATS standards for the optimal management of chronic obstructive pulmonary disease. Respirology 1997;2 Suppl 1:S1-4.
30 Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J 2007;30:993-1013.   DOI   ScienceOn
31 Urbano FL, Pascual RM. Contemporary issues in the care of patients with chronic obstructive pulmonary disease. J Manag Care Pharm 2005;11(5SupplA):S2-13.
32 Enoch T, Nurse P. Coupling M phase and S phase: controls maintaining the dependence of mitosis on chromosome replication. Cell 1991;65:921-3.   DOI   ScienceOn
33 유철규. 만성폐쇄성폐질환의 병인과 병태생리. 대한내과학회지 2009;77:383-400.
34 Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-$1{\beta}$ induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 2001;107:1529-36.   DOI   ScienceOn
35 Keane MP, Strieter RM. The importance of balanced pro-inflammatory and anti-inflammatory mechanism in diffuse lung disease. Respir Res 202;3:5.   DOI   ScienceOn
36 Yoon S, Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 2006;24:21-44.   DOI   ScienceOn
37 Nigg EA. The substrates of the cdc2 kinase. Semin Cell Biol 1991;2:261-70.
38 Nigg EA, Krek W, Peter M. Vertebrate cdc2 kinase: its regulation by phosphorylation and its mitotic targets. Cold Spring Harb Symp Quant Biol 1991;56:539-47.   DOI   ScienceOn